| [1] |
Siegel RL， Giaquinto AN， Jemal A．Cancer statistics，2024[J]. CA Cancer J Clin， 2024， 74(1)：12-49.DOI： 10.3322/caac.21820.
|
| [2] |
Feng RM， Zong YN， Cao SM，et al.Current cancer situation in China：good or bad news from the 2018 Global Cancer Statistics？[J]. Cancer Commun (Lond)， 2019， 39(1)：22.DOI： 10.1186/s40880-019-0368-6.
|
| [3] |
Pavlova NN， Zhu J， Thompson CB.The hallmarks of cancer metabolism：still emerging[J]. Cell Metab， 2022， 34(3)：355-377.DOI： 10.1016/j.cmet.2022.01.007.
|
| [4] |
|
| [5] |
Martínez-Reyes I， Chandel NS.Cancer metabolism：looking forward[J]. Nat Rev Cancer， 2021， 21(10)：669-680.DOI： 10.1038/s41568-021-00378-6.
|
| [6] |
Feng Y， Xiong Y， Qiao T，et al.Lactate dehydrogenase A：a key player in carcinogenesis and potential target in cancer therapy[J]. Cancer Med， 2018， 7(12)：6124-6136.DOI： 10.1002/cam4.1820.
|
| [7] |
Claps G， Faouzi S， Quidville V，et al.The multiple roles of LDH in cancer[J]. Nat Rev Clin Oncol， 2022， 19(12)：749-762.DOI： 10.1038/s41571-022-00686-2.
|
| [8] |
Wu HF， Liu H， Zhang ZW，et al.CENPE and LDHA were potential prognostic biomarkers of chromophobe renal cell carcinoma[J]. Eur J Med Res， 2023， 28(1)：481.DOI： 10.1186/s40001-023-01449-0.
|
| [9] |
Wu C， Zheng C， Chen S，et al.FOXQ1 promotes pancreatic cancer cell proliferation，tumor stemness，invasion and metastasis through regulation of LDHA-mediated aerobic glycolysis[J]. Cell Death Dis， 2023， 14(10)：699.DOI： 10.1038/s41419-023-06207-y.
|
| [10] |
Chen J， Wu F， Cao Y，et al.The novel role of LDHA/LDHB in the prognostic value and tumor-immune infiltration in clear cell renal cell carcinoma[J]. PeerJ， 2023(11)：e15749.DOI： 10.7717/peerj.15749.
|
| [11] |
Xiao X， Huang X， Ye F，et al.The miR-34a-LDHA axis regulates glucose metabolism and tumor growth in breast cancer[J]. Sci Rep， 2016(6)：21735.DOI： 10.1038/srep21735.
|
| [12] |
Rizwan A， Serganova I， Khanin R，et al.Relationships between LDH-A，lactate，and metastases in 4T1 breast tumors[J]. Clin Cancer Res， 2013， 19(18)：5158-5169.DOI： 10.1158/1078-0432.CCR-12-3300.
|
| [13] |
Serganova I， Cohen IJ， Vemuri K，et al.LDH-A regulates the tumor microenvironment via HIF-signaling and modulates the immune response[J]. PLoS One， 2018， 13(9)：e0203965.DOI： 10.1371/journal.pone.0203965.
|
| [14] |
Karami Fath M， Garousi S， Mottahedi M，et al.The role of hypoxia-inducible factors in breast cancer stem cell specification[J]. Pathol Res Pract， 2023(243)：154349.DOI： 10.1016/j.prp.2023.154349.
|
| [15] |
Yu JM， Sun W， Wang ZH，et al.TRIB3 supports breast cancer stemness by suppressing FOXO1 degradation and enhancing SOX2 transcription[J]. Nat Commun， 2019， 10(1)：5720.DOI： 10.1038/s41467-019-13700-6.
|
| [16] |
Brooks MD， Burness ML， Wicha MS.Therapeutic implications of cellular heterogeneity and plasticity in breast cancer[J]. Cell Stem Cell， 2015， 17(3)：260-271.DOI： 10.1016/j.stem.2015.08.014.
|
| [17] |
Wang S， Ma L， Wang Z，et al.Lactate dehydrogenase-a (LDH-A) preserves cancer stemness and recruitment of tumor-associated macrophages to promote breast cancer progression[J]. Front Oncol， 2021(11)：654452.DOI： 10.3389/fonc.2021.654452.
|
| [18] |
Allison SJ， Knight JR， Granchi C，et al.Identification of LDH-A as a therapeutic target for cancer cell killing via (i) p53/NAD(H)-dependent and (ii) p53-independent pathways[J]. Oncogenesis， 2014， 3(5)：e102.DOI： 10.1038/oncsis.2014.16.
|
| [19] |
Chung TW， Kim EY， Han CW，et al.Machilin a inhibits tumor growth and macrophage M2 polarization through the reduction of lactic acid[J]. Cancers (Basel)， 2019， 11(7).DOI： 10.3390/cancers11070963.
|
| [20] |
Le A， Cooper CR， Gouw AM，et al.Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression[J]. Proc Natl Acad Sci U S A， 2010， 107(5)：2037-2042.DOI： 10.1073/pnas.0914433107.
|
| [21] |
Wang S， Yu G， Wang Z，et al.Enhanced antitumor efficacy by a cascade of reactive oxygen species generation and drug release[J]. Angew Chem Int Ed Engl， 2019， 58(41)：14758-14763.DOI： 10.1002/anie.201908997.
|
| [22] |
Wang ZY， Loo TY， Shen JG，et al.LDH-A silencing suppresses breast cancer tumorigenicity through induction of oxidative stress mediated mitochondrial pathway apoptosis[J]. Breast Cancer Res Treat， 2012， 131(3)：791-800.DOI： 10.1007/s10549-011-1466-6.
|
| [23] |
|
| [24] |
|
| [25] |
Feng R， Morine Y， Ikemoto T，et al.Nrf2 activation drive macrophages polarization and cancer cell epithelial-mesenchymal transition during interaction[J]. Cell Commun Signal， 2018， 16(1)：54.DOI： 10.1186/s12964-018-0262-x.
|
| [26] |
Chen P， Zuo H， Xiong H，et al.Gpr132 sensing of lactate mediates tumor-macrophage interplay to promote breast cancer metastasis[J]. Proc Natl Acad Sci U S A， 2017， 114(3)：580-585.DOI： 10.1073/pnas.1614035114.
|
| [27] |
Brand A， Singer K， Koehl GE，et al.LDHA-associated lactic acid production blunts tumor immunosurveillance by T and NK cells[J]. Cell Metab， 2016， 24(5)：657-671.DOI： 10.1016/j.cmet.2016.08.011.
|
| [28] |
丁振罗．LDHA、MCT4和B7-H3在三阴性乳腺癌新辅助化疗疗效评价中的临床意义[D] .南昌：南昌大学医学部，2023.
|
| [29] |
Long Y, Gao Z, Hu X, et al. Downregulation of MCT4 for lactate exchange promotes the cytotoxicity of NK cells in breast carcinoma[J]. Cancer Med， 2018， 7(9)：4690-4700.DOI： 10.1002/cam4.1713.
|
| [30] |
Colegio OR， Chu NQ， Szabo AL，et al.Functional polarization of tumour-associated macrophages by tumour-derived lactic acid[J]. Nature， 2014， 513(7519)：559-563.DOI： 10.1038/nature13490.
|
| [31] |
Qian BZ， Li J， Zhang H，et al.CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis[J]. Nature， 2011， 475(7355)：222-225.DOI： 10.1038/nature10138.
|
| [32] |
Husain Z， Huang Y， Seth P，et al.Tumor-derived lactate modifies antitumor immune response：effect on myeloid-derived suppressor cells and NK cells[J]. J Immunol， 2013， 191(3)：1486-1495.DOI： 10.4049/jimmunol.1202702.
|
| [33] |
Fischer K， Hoffmann P， Voelkl S，et al.Inhibitory effect of tumor cell-derived lactic acid on human T cells[J]. Blood， 2007， 109(9)：3812-3819.DOI： 10.1182/blood-2006-07-035972.
|
| [34] |
Jin L， Chun J， Pan C，et al.Phosphorylation-mediated activation of LDHA promotes cancer cell invasion and tumour metastasis[J]. Oncogene， 2017， 36(27)：3797-3806.DOI： 10.1038/onc.2017.6.
|
| [35] |
Wu Z， Wu J， Zhao Q，et al.Emerging roles of aerobic glycolysis in breast cancer[J]. Clin Transl Oncol， 2020， 22(5)：631-646.DOI： 10.1007/s12094-019-02187-8.
|
| [36] |
Chen X， Luo R， Zhang Y，et al.Long noncoding RNA DIO3OS induces glycolytic-dominant metabolic reprogramming to promote aromatase inhibitor resistance in breast cancer[J]. Nat Commun， 2022， 13(1)：7160.DOI： 10.1038/s41467-022-34702-x.
|
| [37] |
de la Cruz-López KG， Castro-Muñoz LJ， Reyes-Hernández DO，et al.Lactate in the regulation of tumor microenvironment and therapeutic approaches[J]. Front Oncol， 2019(9)：1143.DOI： 10.3389/fonc.2019.01143.
|
| [38] |
Giatromanolaki A， Gkegka AG， Pouliliou S，et al.Hypoxia and anaerobic metabolism relate with immunologically cold breast cancer and poor prognosis[J]. Breast Cancer Res Treat， 2022， 194(1)：13-23.DOI： 10.1007/s10549-022-06609-0.
|
| [39] |
Zagami P, Carey LA. Triple negative breast cancer：pitfalls and progress[J]. NPJ Breast Cancer， 2022， 8(1)：95.DOI： 10.1038/s41523-022-00468-0.
|
| [40] |
Doyen J， Trastour C， Ettore F，et al.Expression of the hypoxia-inducible monocarboxylate transporter MCT4 is increased in triple negative breast cancer and correlates independently with clinical outcome[J]. Biochem Biophys Res Commun， 2014， 451(1)：54-61.DOI： 10.1016/j.bbrc.2014.07.050.
|
| [41] |
Liu Q， Guan C， Liu C，et al.Targeting hypoxia-inducible factor-1alpha：a new strategy for triple-negative breast cancer therapy[J]. Biomed Pharmacother， 2022(156)：113861.DOI： 10.1016/j.biopha.2022.113861.
|
| [42] |
Brown JE， Cook RJ， Lipton A，et al.Serum lactate dehydrogenase is prognostic for survival in patients with bone metastases from breast cancer：a retrospective analysis in bisphosphonate-treated patients[J]. Clin Cancer Res， 2012， 18(22)：6348-6355.DOI： 10.1158/1078-0432.CCR-12-1397.
|
| [43] |
|
| [44] |
Hussien R， Brooks GA.Mitochondrial and plasma membrane lactate transporter and lactate dehydrogenase isoform expression in breast cancer cell lines[J]. Physiol Genomics， 2011， 43(5)：255-264.DOI： 10.1152/physiolgenomics.00177.2010.
|
| [45] |
Gottfried E， Lang SA， Renner K，et al.New aspects of an old drug-diclofenac targets MYC and glucose metabolism in tumor cells[J]. PLoS One， 2013， 8(7)：e66987.DOI： 10.1371/journal.pone.0066987.
|
| [46] |
Farabegoli F, Vettraino M, Manerba M, et al. Galloflavin, a new lactate dehydrogenase inhibitor，induces the death of human breast cancer cells with different glycolytic attitude by affecting distinct signaling pathways[J]. Eur J Pharm Sci， 2012， 47(4)：729-738.DOI： 10.1016/j.ejps.2012.08.012.
|
| [47] |
Kim EY， Chung TW， Han CW，et al.A novel lactate dehydrogenase inhibitor，1-(Phenylseleno)-4-(Trifluoromethyl) benzene，suppresses tumor growth through apoptotic cell death[J]. Sci Rep， 2019， 9(1)：3969.DOI： 10.1038/s41598-019-40617-3.
|
| [48] |
Altinoz MA， Ozpinar A．Oxamate targeting aggressive cancers with special emphasis to brain tumors[J]. Biomed Pharmacother， 2022(147)：112686.DOI： 10.1016/j.biopha.2022.112686.
|
| [49] |
Das CK， Parekh A， Parida PK，et al.Lactate dehydrogenase A regulates autophagy and tamoxifen resistance in breast cancer[J]. Biochim Biophys Acta Mol Cell Res， 2019， 1866(6)：1004-1018.DOI： 10.1016/j.bbamcr.2019.03.004.
|